Ilex Medical Ltd (TLV:ILX)

Ilex Medical Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	177.25	148.38	200.96	259.23	159.83
Short-Term Investments	25.87	41.25	2.74	-	-
Trading Asset Securities	30.51	27.48	22	25.52	15.93
Cash & Short-Term Investments	233.63	217.11	225.7	284.75	175.75
Cash Growth	7.61%	-3.81%	-20.74%	62.02%	101.31%
Accounts Receivable	249.37	286.25	248.26	219.99	239.46
Other Receivables	17.56	15.57	3.04	3.73	0.38
Receivables	266.93	301.82	251.3	223.72	239.84
Inventory	157.89	159.68	145.8	116.32	136.68
Other Current Assets	60.02	7.39	12.02	6.93	6.72
Total Current Assets	718.47	686.01	634.83	631.72	558.99
Property, Plant & Equipment	155.46	160.91	145.28	151.41	154.78
Long-Term Investments	53.71	57.95	72.66	32.1	0.45
Goodwill	7.01	7.01	7.01	-	-
Other Intangible Assets	17.08	21.18	25.06	25.87	31.69
Long-Term Accounts Receivable	-	28.51	5.73	3.75	6.42
Long-Term Deferred Tax Assets	7.42	8.51	6.35	6.35	4.46
Long-Term Deferred Charges	-	0.08	0.04	0.08	0.08
Other Long-Term Assets	34.92	45.95	2.23	23.8	22.38
Total Assets	994.07	1,016	899.18	875.07	779.25
Accounts Payable	120.44	172.11	142.32	124.39	162.79
Accrued Expenses	-	-	-	-	40.2
Short-Term Debt	-	-	-	-	0.22
Current Portion of Long-Term Debt	0.31	0.41	0.56	1.13	15.27
Current Portion of Leases	12.22	11.47	12.28	11.96	8.56
Current Income Taxes Payable	4.5	1.4	2.22	40.39	7.22
Current Unearned Revenue	-	-	-	-	33.4
Other Current Liabilities	130.4	93.15	68.45	62.23	11.58
Total Current Liabilities	267.87	278.54	225.83	240.11	279.22
Long-Term Debt	-	0.31	0.73	1.29	2.42
Long-Term Leases	38.81	36.07	37.99	44.36	40.28
Long-Term Unearned Revenue	25.28	60.33	4.11	-	6.08
Long-Term Deferred Tax Liabilities	2.55	2.94	3.15	6.72	7.58
Other Long-Term Liabilities	12.12	12.77	14.28	7.02	0.12
Total Liabilities	347.58	392.61	286.08	299.49	335.71
Common Stock	12.48	12.48	12.48	12.48	12.48
Additional Paid-In Capital	150.5	150.5	150.5	150.5	150.5
Retained Earnings	568.58	544.92	515.41	472.39	334.63
Treasury Stock	-9.2	-9.2	-3.49	-	-
Comprehensive Income & Other	-75.86	-75.19	-61.79	-59.79	-54.07
Total Common Equity	646.49	623.51	613.1	575.57	443.54
Shareholders' Equity	646.49	623.51	613.1	575.57	443.54
Total Liabilities & Equity	994.07	1,016	899.18	875.07	779.25
Total Debt	51.35	48.27	51.55	58.74	66.74
Net Cash (Debt)	182.28	168.84	174.15	226.02	109.01
Net Cash Growth	7.96%	-3.04%	-22.95%	107.33%	-
Net Cash Per Share	16.32	15.09	15.44	20.04	10.22
Filing Date Shares Outstanding	11.17	11.28	11.28	11.28	11.28
Total Common Shares Outstanding	11.17	11.19	11.25	11.28	11.28
Working Capital	450.6	407.47	409	391.61	279.77
Book Value Per Share	57.88	55.73	54.52	51.02	39.32
Tangible Book Value	622.4	595.32	581.04	549.7	411.85
Tangible Book Value Per Share	55.72	53.21	51.67	48.73	36.51
Land	-	0.06	0.06	0.06	0.06
Machinery	-	244.49	212.94	193.36	188.2
Leasehold Improvements	-	25.19	24.04	25.51	25.36

Updated Nov 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.